Show Summary Details
Page of

The Use of the Pulmonary Artery Catheter in Critical Care: The PAC-Man Trial 

The Use of the Pulmonary Artery Catheter in Critical Care: The PAC-Man Trial
Chapter:
The Use of the Pulmonary Artery Catheter in Critical Care: The PAC-Man Trial
Author(s):

Shahzad Shaefi

, and Ameeka Pannu

DOI:
10.1093/med/9780190467654.003.0012
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 24 May 2019

The PAC-Man trial published in 2005 was a prospective randomized controlled trial in the United Kingdom that examined the effectiveness of the use of the pulmonary artery catheter (PAC). Critically ill adults were randomized to management with or without a PAC with further treatment at the discretion of the treating physician. The study noted no difference in hospital mortality between these groups; in addition, ICU and hospital lengths of stay were similar. While use of a PAC was randomized, this study did not examine whether PAC data was correctly collected or interpreted when used to make decisions. There appears to be no clear mortality benefit to using PA catheters to manage critically ill patients despite clinicians in this study using PAC-derived data to guide treatment. Given this conclusion and risks associated with PAC placement, we recommend that a decision to place a PAC be made on a case-to-case basis.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.